ERIC RAVUSSIN
Estados Unidos
Dr. Eric Ravussin is a Boyd Professor at Louisiana State University. He received his PhD in human
physiology at the University of Lausanne, Switzerland. Dr. Ravussin is an internationally recognized
translational investigator in obesity and diabetes research. His research now focuses on the molecular
basis of obesity and its co-morbidities. His studies are aimed at understanding the molecular
mechanisms that determine the inter-individual variability in energy expenditure, fat oxidation and
energy balance in response to caloric restriction, increased or decreased physical activity, overfeeding or
physiological conditions such as puberty, pregnancy, or menopause as well as pharmacological
treatment. His latest research is in the field of aging with an emphasis on the impact of caloric
restriction on human biomarkers of aging and longevity. Dr. Ravussin has published more than 700 peer
reviewed manuscripts in the field of obesity, type 2 diabetes, and aging. He has an h index of >115 and
has mentored more than 60 postdoctoral fellows. Dr. Ravussin has been the recipient of multiple awards
and just ended his 10-y commitment as Editor in Chief of Obesity since 2012.
Estados Unidos
Dr. Eric Ravussin is a Boyd Professor at Louisiana State University. He received his PhD in human
physiology at the University of Lausanne, Switzerland. Dr. Ravussin is an internationally recognized
translational investigator in obesity and diabetes research. His research now focuses on the molecular
basis of obesity and its co-morbidities. His studies are aimed at understanding the molecular
mechanisms that determine the inter-individual variability in energy expenditure, fat oxidation and
energy balance in response to caloric restriction, increased or decreased physical activity, overfeeding or
physiological conditions such as puberty, pregnancy, or menopause as well as pharmacological
treatment. His latest research is in the field of aging with an emphasis on the impact of caloric
restriction on human biomarkers of aging and longevity. Dr. Ravussin has published more than 700 peer
reviewed manuscripts in the field of obesity, type 2 diabetes, and aging. He has an h index of >115 and
has mentored more than 60 postdoctoral fellows. Dr. Ravussin has been the recipient of multiple awards
and just ended his 10-y commitment as Editor in Chief of Obesity since 2012.